The All India Institute of Medical Sciences (AIIMS) in Delhi is all set to conduct the trial of Covaxin's second dose on children aged 2-6 years. The trial will begin next week. AIIMS had previously vaccinated children aged 6-12 with the second dose of Bharat Biotech's Covaxin. from IndiaTV India: Google News Feed https://ift.tt/3zFvlxp
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.